Estados financieros detallados de Achieve Life Sciences, Inc. (ACHV): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $7.42, ACHV presenta beneficios negativos (P/E no significativo) y un ROE del -8.92%. La capitalización bursátil es de $762M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $5.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $282000 | $282000 | $254000 | $255000 | 0 | 0 | 0 | $229000 | $228000 |
| Beneficio Bruto | $5.1M | -$282000 | -$282000 | -$254000 | -$255000 | 0 | 0 | 0 | -$229000 | -$228000 |
| I+D | $14.8M | $3.1M | $5.9M | $9.7M | $6.9M | $24.0M | $30.1M | $15.8M | $22.8M | $23.0M |
| Generales y Administrativos | $8.9M | $3.5M | $6.9M | $6.9M | $7.6M | $9.1M | $10.7M | $11.4M | $16.3M | $31.9M |
| Gastos Operativos | $23.7M | $6.6M | $12.8M | $16.5M | $14.5M | $33.1M | $40.8M | $27.2M | $38.8M | $54.7M |
| Beneficio Operativo | -$21.2M | -$6.6M | -$12.8M | -$16.5M | -$14.8M | -$33.1M | -$40.8M | -$27.2M | -$39.1M | -$54.9M |
| EBITDA | -$19.9M | -$13.4M | -$12.4M | -$16.1M | -$14.5M | -$32.9M | -$40.3M | -$26.7M | -$37.4M | -$53.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M | $2.9M | $2.2M | $819000 |
| Beneficio Antes de Impuestos | -$20.1M | -$13.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| Impuestos | -$1.1M | -$3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.1M | -$10.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| BPA | $-1478.66 | $-441.47 | $-72.29 | $-39.15 | $-5.39 | $-4.05 | $-3.95 | $-1.50 | $-1.24 | $-1.25 |
| BPA Diluido | $-1474.98 | $-441.47 | $-72.29 | $-39.15 | $-5.39 | $-4.05 | $-3.95 | $-1.50 | $-1.24 | $-1.25 |
| Acciones en Circulación (Diluidas) | $13647 | $23972 | $175511 | $412320 | $2.7M | $8.1M | $10.6M | $19.8M | $32.1M | $43.6M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $15.2M | $5.3M | $9.5M | $16.7M | $35.9M | $43.0M | $24.7M | $15.5M | $12.7M | $20.9M |
| Inversiones a Corto | $10.2M | 0 | $5.1M | 0 | 0 | 0 | 0 | 0 | $21.6M | $15.5M |
| Cuentas por Cobrar | $510000 | $9000 | $7000 | $8000 | 0 | $153000 | $105000 | $111000 | 0 | 0 |
| Inventario | 0 | $222000 | -$50000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $27.2M | $5.9M | $15.5M | $17.3M | $37.0M | $44.6M | $27.3M | $17.0M | $36.5M | $39.9M |
| Inmovilizado Material | $271000 | $59000 | $35000 | $386000 | $146000 | $64000 | $123000 | $79000 | $119000 | $64000 |
| Fondo de Comercio | $1034 | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M |
| Activos Intangibles | $2755 | $2.5M | $2.3M | $2.1M | $1.9M | $1.6M | $1.4M | $1.2M | $974000 | $751000 |
| Activos Totales | $27.5M | $9.9M | $19.1M | $21.1M | $40.3M | $47.5M | $30.0M | $19.4M | $38.6M | $41.8M |
| Cuentas por Pagar | $2.1M | $213000 | $144000 | $859000 | $332000 | $841000 | $1.7M | $618000 | $1.9M | $867000 |
| Deuda a Corto | $829000 | 0 | 0 | 0 | 0 | 0 | $16.1M | $16.7M | 0 | $3.7M |
| Pasivos Corrientes | $8.5M | $2.0M | $3.3M | $2.9M | $2.9M | $4.5M | $21.6M | $20.8M | $6.7M | $9.1M |
| Deuda a Largo | 0 | 0 | $12000 | 0 | 0 | $14.9M | 0 | 0 | $9.8M | $11.2M |
| Pasivos Totales | $8.5M | $2.0M | $3.3M | $3.0M | $3.0M | $19.5M | $21.7M | $20.8M | $17.7M | $20.3M |
| Reservas | -$196.9M | -$12.7M | -$25.4M | -$45.7M | -$60.4M | -$93.6M | -$135.9M | -$165.8M | -$205.6M | -$260.2M |
| Patrimonio Neto | $19.0M | $7.9M | $15.8M | $18.1M | $37.3M | $28.0M | $8.3M | -$1.4M | $20.9M | $21.5M |
| Deuda Total | $106000 | $27000 | $35000 | $362000 | $169000 | $15.0M | $16.2M | $16.7M | $10.0M | $15.0M |
| Deuda Neta | -$25.6M | -$5.3M | -$14.6M | -$16.3M | -$35.7M | -$28.0M | -$8.5M | $1.2M | -$24.4M | -$21.4M |
| Capital Circulante | $18.7M | $3.9M | $12.3M | $14.5M | $34.0M | $40.0M | $5.7M | -$3.8M | $29.8M | $30.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$20.1M | -$10.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| Amortizaciones | $188000 | $282000 | $282000 | $254000 | $255000 | $250000 | $236000 | $228000 | $229000 | $228000 |
| Compensación en Acciones | $1.6M | $348000 | $854000 | $1.2M | $1.3M | $2.2M | $3.3M | $3.4M | $5.3M | $8.8M |
| Cambio en Capital Circulante | -$10.7M | -$3.1M | $928000 | -$273000 | -$285000 | $1.2M | $79000 | -$778000 | $2.4M | -$4.3M |
| Flujo de Caja Operativo | -$29.7M | -$9.1M | -$10.6M | -$15.2M | -$13.5M | -$29.4M | -$37.6M | -$24.5M | -$29.8M | -$49.5M |
| Inversiones (CapEx) | -$46000 | 0 | -$46000 | -$53000 | -$17000 | 0 | 0 | -$21000 | 0 | -$3000 |
| Adquisiciones | 0 | $12.6M | $10000 | -$5089 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$30000 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$29.7M | -$9.1M | -$10.7M | -$15.3M | -$13.5M | -$29.4M | -$37.6M | -$24.5M | -$29.8M | -$49.5M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -100.0% | |||||||||
| Crecimiento Beneficio Neto (anual) | +47.4% | -19.9% | -29.2% | +10.6% | -126.1% | -27.7% | +29.6% | -33.6% | -37.2% | |
| Crecimiento BPA (anual) | +70.1% | +83.6% | +45.8% | +86.2% | +24.9% | +2.5% | +62.0% | +17.3% | -0.8% | |
| Cambio en Acciones (anual) | +75.7% | +632.2% | +134.9% | +559.4% | +198.6% | +30.5% | +87.2% | +61.8% | +35.9% | |
| Crecimiento FCF (anual) | +69.4% | -17.2% | -43.1% | +11.6% | -118.2% | -27.6% | +34.8% | -21.5% | -66.2% | |
| Margen Bruto | 100.0% | |||||||||
| Margen Operativo | -418.6% | |||||||||
| Margen EBITDA | -393.9% | |||||||||
| Margen Neto | -397.6% | |||||||||
| Margen FCF | -587.3% | |||||||||
| Tasa Impositiva Efectiva | 5.3% | 22.4% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2178.43 | $-379.90 | $-60.79 | $-37.03 | $-4.96 | $-3.63 | $-3.55 | $-1.24 | $-0.93 | $-1.13 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $13613 | $23972 | $175510 | $412320 | $2.7M | $8.1M | $10.6M | $19.8M | $32.1M | $43.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -892.07% |
| Rentabilidad sobre capital invertido | -21425.74% |
| Rentabilidad sobre activos | -59.88% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -1.02 |
| Ratio corriente | 0.95 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -0.74 | -0.61 | -0.33 | -0.27 | -1.50 | -1.92 | -0.62 | -2.75 | -2.84 | -3.98 |
| P/VC | 0.79 | 0.82 | 0.27 | 0.24 | 0.59 | 2.25 | 3.13 | -56.41 | 5.40 | 10.07 |
| P/V | 2.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -418.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -397.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ALLO · ARCT · AVIR · CAPR · HUMA · IMRX · SGMT
Explorar sector: Healthcare · Biotechnology
Más secciones de ACHV: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones